Navigation Links
LUNGevity Hosts Post-ASCO Lung Cancer Recap
Date:6/18/2011

WASHINGTON, June 18, 2011 /PRNewswire-USNewswire/ -- LUNGevity Foundation and GRACE announce a free webinar program to provide the highlights in lung cancer research from the American Society for Clinical Oncology (ASCO) Annual Meeting held June 3-6, 2011 in Chicago.  ASCO, the largest cancer conference of the year, is where the majority of the landmark clinical research in cancer care are presented.  On the webinar participants will learn the results of the key research and also have it placed into context with valuable commentary by two expert lung cancer oncologists. For more information and to register, visit http://events.lungevity.org/site/PageServer?pagename=podcasts_webinars.

About LUNGevity Foundation

The mission of LUNGevity Foundation is to have a meaningful and immediate impact on improving lung cancer survival rates, ensure a higher quality of life for lung cancer patients, and provide a community for those impacted by lung cancer.

In order to accomplish its mission, LUNGevity funds the most promising research into the early detection and successful treatment of lung cancer as identified by its board of leading scientists. LUNGevity also supports the largest national grassroots lung cancer network.

LUNGevity seeks to inspire the nation to commit to ending lung cancer.

For more information, please visit www.lungevity.org.

About Lung Cancer

  • Lung cancer impacts 1 in 14 Americans and is the number one cancer killer.
  • About 65 percent of Americans diagnosed with lung cancer either never smoked a cigarette in their lives or had quit smoking.
  • Less than 15 percent of people diagnosed with lung cancer survive 5 years post-diagnosis because of limited early detection opportunities.
  • There is no widely available, effective early diagnostic test available today.

About GRACE

The mission of the Global Resource for Advancing Cancer Education (GRACE) is to provide expert-mediated information on current and emerging cancer management options in order to empower patients, caregivers, and health professionals to become direct partners in cancer care. GRACE (www.cancerGRACE.org) was founded by Dr. Howard (Jack) West, a medical oncologist based in Seattle, to provide high quality, expert-mediated cancer information for the general public, specifically for patients, their families, and other caregivers, that is not available through other sources.  Since its inception, its faculty, breadth and depth of content, and international audience have grown rapidly.


'/>"/>
SOURCE LUNGevity Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. KGI Hosts Fourth Annual Conference for Women in Life Science Industry
2. J. Craig Venter Institute Hosts Genomics Education Program for DC Metro Area Teachers
3. Stevens hosts 2010 metro area NEMS/MEMS Workshop
4. Yongye International Hosts Official NASDAQ Visit to Inner Mongolia
5. Parasite plants rob genes from their hosts
6. GenomeQuest Hosts IP Workshop at Annual PIUG Conference in Baltimore
7. Toxikon Corporation Hosts Extractables and Leachables Spring Seminar
8. Chinese Biopharaceutical Association Hosts 2010 Chinese New Year Gala in Washington, DC
9. The American Society for Laser Medicine and Surgery Hosts Its 30th Annual Conference in Phoenix on April 14-18, 2010
10. Abbott Hosts Conference Call for Third-Quarter Earnings
11. CBI Hosts Life Sciences Summit on International Trade Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 2016  In the pharmaceutical industry the medical affairs ... launch activities including the identification and engagement of key ... especially high in the oncology therapeutic area where most ... the Role of Medical Affairs in Oncology Launch Excellence ... therapies find better ways to utilize medical affairs to ...
(Date:2/5/2016)... -- Amarantus BioScience Holdings, Inc. ... products for Regenerative Medicine, Neurology and Orphan Diseases, announced ... from the US Food and Drug Administration (FDA) for ... granted orphan drug designation (ODD) by the US FDA ... Inc. (OTCQB: AMBS), a biotechnology company ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... compliance training, today announced an interactive FDA compliance training course, ... (Regulatory Affairs Professional Society) accredited interactive course on Morf Playbook—now conveniently available on ...
(Date:2/4/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the ... Edward Lanphier , Sangamo,s president and chief executive officer, ... ZFP Therapeutic ® development programs and an overview ... on Thursday, February 11, 2016, at the Leerink Partners ... is being held in New York ...
Breaking Biology Technology:
(Date:2/3/2016)... 2016 --> --> Fourth ... (105.0), up 1,187% compared with fourth quarter of 2014. Gross ... M (loss: 30.0). Earnings per share increased to SEK 6.39 ... M (neg: 74.7). , --> ... SEK 2,900.5 M (233.6), up 1,142% compared with 2014. Gross ...
(Date:2/3/2016)... , Feb. 3, 2016 ... the addition of the "Emotion Detection ... Machine Learning, and Others), Software Tools (Facial ... Areas, End Users,and Regions - Global forecast ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has ...
(Date:2/2/2016)... 2, 2016 Checkpoint Inhibitors for Cancer ... Are you interested in the future of ... checkpoint inhibitors. Visiongain,s report gives those predictions to ... national level. Avoid falling behind in data ... and revenues those emerging cancer therapies can achieve. ...
Breaking Biology News(10 mins):